Six weeks a lot longer than three weeks, perhaps too long for many.
Those wishing to gain, certainly need be looking for pre-reporting changes in direction.
Looking at two year chart, trend has been slowly upwards.
IMHO the price drop after 26 July market update further than justified... though yet to really recover.
Expect see creep over next 3 weeks as move through reporting season - pre-report mode, so watch for movements.
Isolating those reflecting internal knowledge a task best left to the appointed authorities...
Two year chart, shows trend slowly upwards :-) expect see this re-appear over next three weeks.
Some large single buys recently, while volume appears down from daily average, while no shortage of tiny chip-away-at-price trades so the professionals still busy.
ABC today reporting we still pay higher than average prices for medicines.
My first thought was to see generics as possible area for gains, though admit not sure at all sure.
Will SIP gain - or lose, from gov and other pressures to encouraging greater usage of generic medicines so reduce cost of brands ?
SIP Price at posting:
64.7¢ Sentiment: LT Buy Disclosure: Held
